Sergo Vashakidze

Sergo Vashakidze

UNVERIFIED PROFILE

Are you Sergo Vashakidze?   Register this Author

Register author
Sergo Vashakidze

Sergo Vashakidze

Publications by authors named "Sergo Vashakidze"

Are you Sergo Vashakidze?   Register this Author

12Publications

-Reads

Reply to Srivastava et al., "pH Conditions under Which Pyrazinamide Works in Humans".

Antimicrob Agents Chemother 2017 Sep 24;61(9). Epub 2017 Aug 24.

National Center for Tuberculosis and Lung Disease, Tbilisi, Georgia.

View Article
September 2017

Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia.

Int J Infect Dis 2017 Mar 19;56:200-207. Epub 2016 Dec 19.

Experimental Tuberculosis Unit (UTE). Fundació Institut Germans Trias i Pujol (IGTP). Universitat Autònoma de Barcelona (UAB). Edifici Laboratoris de Recerca. Can Ruti Campus. Crtra. de Can Ruti, Camí de les Escoles, s/n. 08916, Badalona, Catalonia; Spain; CIBER Enfermedades Respiratorias, Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0. 28029, Madrid, Spain. Electronic address:

View Article
March 2017

Development of the food supplement Nyaditum resae as a new tool to reduce the risk of tuberculosis development.

Int J Mycobacteriol 2016 Dec 14;5 Suppl 1:S101-S102. Epub 2016 Nov 14.

Unitat de Tuberculosi Experimental, Institut Germans Trias i Pujol (IGTP), CIBERES, Universitat Autònoma de Barcelona (UAB), Badalona, Catalonia, Spain. Electronic address:

View Article
December 2016

Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.

Antimicrob Agents Chemother 2015 16;59(6):3149-55. Epub 2015 Mar 16.

Division of Infectious Diseases Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA Departments of Epidemiology and Global Health, Emory Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.

View Article
February 2016

Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.

PLoS One 2013 19;8(12):e83892. Epub 2013 Dec 19.

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America ; Hubert Department of Global Health, Rollins School of Public Health of Emory University, Atlanta, Georgia, United States of America ; Department of Epidemiology, Rollins School of Public Health of Emory University, Atlanta, Georgia, United States of America.

View Article
October 2014

Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.

Ann Thorac Surg 2013 Jun 1;95(6):1892-8. Epub 2013 May 1.

National Center for Tuberculosis and Lung Diseases, Tbilisi, Republic of Georgia.

View Article
June 2013

Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis.

Clin Infect Dis 2012 Mar 23;54(6):e51-4. Epub 2011 Dec 23.

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303, USA.

View Article
March 2012

Surgical treatment of drug-resistant tuberculosis.

Lancet Infect Dis 2012 Feb;12(2):157-66

Division of Infectious Diseases, Department of Medicine, Rollins School of Public Health, Emory University, Atlanta, GA 30303, USA.

View Article
February 2012